Akari Therapeutics (AKTX) Cash & Equivalents Growth (3y) (2014 - 2025)
Akari Therapeutics (AKTX) Cash & Equivalents Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 24.73% |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -40.88% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -28.55% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 21.66% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -16.07% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -8.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.77% |
| Dec 31, 2024 | -34.27% |
| Dec 31, 2022 | 32.22% |
| Dec 31, 2021 | 19.79% |
| Dec 31, 2019 | -44.81% |
| Mar 31, 2019 | -53.58% |
| Dec 31, 2018 | -57.09% |
| Dec 31, 2017 | 103.66% |
| Dec 31, 2016 | 294.91% |
| Dec 31, 2015 | 296.70% |
| Dec 31, 2014 | 721.59% |